{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:20:00Z","timestamp":1790688000918,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,16]]},"DOI":"10.1093\/jnci\/djr028","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T23:23:40Z","timestamp":1298589820000},"page":"462-469","source":"Crossref","is-referenced-by-count":99,"title":["An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection"],"prefix":"10.1093","volume":"103","author":[{"given":"Andrew J.","family":"Vickers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathee","family":"Till","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Tangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"issue":"10","key":"key\n\t\t\t\t20170521012405_bib1","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1200\/JCO.2004.06.157","article-title":"International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument","volume":"22","author":"Burgers","year":"2004","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170521012405_bib2","article-title":"NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer Early Detection","author":"National Comprehensive Cancer Network"},{"issue":"13","key":"key\n\t\t\t\t20170521012405_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20170521012405_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170521012405_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Med"},{"issue":"4","key":"key\n\t\t\t\t20170521012405_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"key\n\t\t\t\t20170521012405_bib7","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa043739","article-title":"Radical prostatectomy versus watchful waiting in early prostate cancer","volume":"352","author":"Bill-Axelson","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20170521012405_bib8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jama.2009.1348","article-title":"Outcomes of localized prostate cancer following conservative management","volume":"302","author":"Lu-Yao","year":"2009","journal-title":"JAMA"},{"issue":"8","key":"key\n\t\t\t\t20170521012405_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"key\n\t\t\t\t20170521012405_bib10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/jnci\/djj410","article-title":"Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability","volume":"98","author":"Carter","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"key\n\t\t\t\t20170521012405_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1200\/JCO.2007.13.1490","article-title":"Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population","volume":"26","author":"Ulmert","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170521012405_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-6-6","article-title":"Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study","volume":"6","author":"Ulmert","year":"2008","journal-title":"BMC Med"},{"issue":"5","key":"key\n\t\t\t\t20170521012405_bib13","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.juro.2009.07.093","article-title":"Prostate specific antigen best practice statement: 2009 update","volume":"182","author":"Greene","year":"2009","journal-title":"J Urol"},{"issue":"3","key":"key\n\t\t\t\t20170521012405_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20170521012405_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cct.2003.11.007","article-title":"Implementation of the Prostate Cancer Prevention Trial (PCPT)","volume":"25","author":"Goodman","year":"2004","journal-title":"Control Clin Trials"},{"issue":"5","key":"key\n\t\t\t\t20170521012405_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20170521012405_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.urology.2007.05.010","article-title":"Prostate-specific antigen velocity risk count assessment: a new concept for detection of life-threatening prostate cancer during window of curability","volume":"70","author":"Carter","year":"2007","journal-title":"Urology"},{"issue":"3","key":"key\n\t\t\t\t20170521012405_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2008.18.1685","article-title":"Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer","volume":"27","author":"Vickers","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170521012405_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.urology.2003.09.083","article-title":"Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)","volume":"63","author":"Roobol","year":"2004","journal-title":"Urology"},{"issue":"2","key":"key\n\t\t\t\t20170521012405_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.eururo.2008.02.046","article-title":"Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)","volume":"55","author":"Wolters","year":"2009","journal-title":"Eur Urol"},{"issue":"6","key":"key\n\t\t\t\t20170521012405_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.urology.2007.12.008","article-title":"Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program","volume":"71","author":"Eggener","year":"2008","journal-title":"Urology"},{"issue":"5","key":"key\n\t\t\t\t20170521012405_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.eururo.2009.07.047","article-title":"Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort","volume":"56","author":"Vickers","year":"2009","journal-title":"Eur Urol"},{"issue":"2","key":"key\n\t\t\t\t20170521012405_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa032975","article-title":"Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy","volume":"351","author":"D\u2019Amico","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"key\n\t\t\t\t20170521012405_bib24","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2008.19.9794","article-title":"Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy","volume":"27","author":"O\u2019Brien","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170521012405_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1200\/JCO.2008.21.5392","article-title":"Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority","volume":"27","author":"Nanda","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/103\/6\/462\/17311461\/djr028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:08:42Z","timestamp":1503619722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djr028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,2,24]]},"published-print":{"date-parts":[[2011,3,16]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djr028","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13277054.14635182","asserted-by":"object"}]},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}